$VERA
Vera Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$33.96
▼-0.91%-$0.312
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVera Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VERA down today? It is at $33.96 (-0.91%), and our scanner flagged it 175 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VERA spikes, and full due diligence on VERA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VERA 175 times in the last 30 days. Create a free account to track $VERA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VERA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VERA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 17, 2026 · 3 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fordyce Marshall Officer | Sold (automatic/other) | -19K 0.03% of company | sold 7.3% | 235K | $685K at $37.00 | Sep 15, 26 |
Fordyce Marshall Officer | Other | 19K 0.03% of company | added 7.9% | 254K | $54K at $2.90 | Sep 15, 26 |
Young Joseph R Officer | Other | 5K | added 6.6% | 81K | $20K at $3.94 | Sep 11, 26 |
Fordyce Marshall Officer | Sold (automatic/other) | -19K 0.03% of company | sold 7.3% | 235K | $650K at $35.12 | Sep 2, 26 |
Fordyce Marshall Officer | Other | 19K 0.03% of company | added 7.9% | 254K | $54K at $2.90 | Sep 2, 26 |
Boman Nancy Lee Officer | Acquired (grant/award) | +45K 0.06% of company | n/a | 45K | n/a | Aug 3, 26 |
Fordyce Marshall Officer | Sold (automatic/other) | -46K 0.06% of company | sold 23% | 152K | $1.9M at $40.78 | Jul 7, 26 |
Fordyce Marshall Officer | Sold (automatic/other) | -19K 0.03% of company | sold 8.5% | 198K | $702K at $37.93 | Jun 23, 26 |
Fordyce Marshall Officer | Sold (automatic/other) | -19K 0.03% of company | sold 7.9% | 217K | $678K at $36.64 | May 12, 26 |
Fordyce Marshall Officer | Sold (automatic/other) | -23K 0.03% of company | sold 8.9% | 235K | $1.0M at $43.66 | Apr 14, 26 |
Wright-Mitchell Jane Officer | Acquired (grant/award) | +42K 0.06% of company | n/a | 42K | n/a | Mar 23, 26 |
Young Joseph R Officer | Other | 10K 0.01% of company | added 15% | 76K | $39K at $3.94 | Mar 13, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on VERA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VERA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VERA last traded at $33.96, down 0.91% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Vera Therapeutics, Inc. Class A Common Stock (VERA) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VERA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VERA 175 times in the last 30 days.
VERA (Vera Therapeutics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $2.45B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VERA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VERA discussion
Sign in to ask a question or join the discussion.